UK
uk
2026
The Health Protection (Notification) (Amendment) Regulations 2026
UK Statutory Instrument
2026 No. 535
PUBLIC HEALTH, ENGLAND
The Health Protection (Notification) (Amendment) Regulations 2026
Made
at 1.01 p.m. on 18th May 2026
Laid before Parliament
at 4.15 p.m. on 18th May 2026
Coming into force
at 6.00 p.m. on 18th May 2026
The Secretary of State makes these Regulations in exercise of the powers conferred by section 45C(1), (2) and (3)(a), 45F(2)(a) and 45P(2) of the Public Health (Control of Disease) Act 1984 .
In accordance with section 45Q(3) of the Public Health (Control of Disease) Act 1984, the Secretary of State is of the opinion that these Regulations do not contain any provision made by virtue of section 45C(3)(c) of that Act which imposes or enables the imposition of a special restriction or requirement or any other restriction or requirement which has or would have a significant effect on a person’s rights.
Citation, commencement, extent and application
1
1
These Regulations may be cited as the Health Protection (Notification) (Amendment) Regulations 2026.
2
These Regulations come into force at 6.00 p.m. on 18th May 2026.
3
These Regulations extend to England and Wales and apply in relation to England only.
Amendment to the Health Protection (Notification) Regulations 2010
2
In Schedule 1 to the Health Protection (Notification) Regulations 2010 , at the appropriate alphabetical place insert—
“ Hantavirus disease, including hantavirus pulmonary or cardiopulmonary syndrome and haemorrhagic fever with renal syndrome ”.
Signed by the authority of the Secretary of State for Health and Social Care
Sharon Hodgson
Parliamentary Under-Secretary of State
Department of Health and Social Care
at 1.01 p.m. on 18th May 2026
EXPLANATORY NOTE
(This note is not part of the Regulations)
These Regulations amend the Health Protection (Notification) Regulations 2010 ( S.I. 2010/659 ). They apply in relation to England only. Regulation 2 adds hantavirus disease, including hantavirus pulmonary or cardiopulmonary syndrome and haemorrhagic fever with renal syndrome to the list of notifiable diseases in Schedule 1.
A full impact assessment has not been produced for this instrument because no, or no significant, impact on the private, voluntary or public sector is foreseen.
